88149613 - RNA TO GO

Information

• Trademark
• 88149613

• Source

• Serial Number

  88149613

• Registration Number

  5918021

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  October 10, 2018
  6 years ago

• Registration Date

  November 26, 2019
  5 years ago

• Transaction Date

  December 05, 2024
  21 days ago

• Status Date

  November 26, 2019
  5 years ago

• Published for Opposition Date

  September 10, 2019
  5 years ago

• Location Date

  November 26, 2019
  5 years ago

• Status Code

  700

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  POLLACK, ALISON

• Attorney Docket Number

  067249-0029

  Attorney Name

  Jennifer Fraser

  Law Office Assigned Location Code

  L60

• Owners

  • CUREVAC AG

Case File Statements

• GS0051: Chemical preparations for medical use, namely, for therapeutic and prophylactic treatment of neurological, neuromuscular, neurodegenerative, infectious and cardiovascular diseases, of autoimmune diseases and tumours, of allergies, of metabolic diseases, of heritable genetic diseases, and for therapies replacing proteins or enzymes; pharmaceutical preparations, namely, immunostimulants, in particular for human or veterinary medical purposes; pharmaceutical preparations, namely, vaccines, in particular for human or veterinary medical purposes; pharmaceutical preparations, namely, adjuvant immunostimulants; pharmaceuticals and medicaments containing biological macromolecules, in particular for human or veterinary purposes for the treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, for the treatment of infectious diseases, autoimmune diseases and tumours, for treatment of metabolic diseases and for treatment of heritable genetic diseases and for protein or enzyme replacement therapy; gene therapy products, namely, nucleic acid macromolecules for in vivo expression for human or veterinary medical use; Dietetic substances adapted for medical use, in particular substances for food supplements namely, dietary food supplements
• GS0011: Chemical reagents and biomolecules, in particular biological macromolecules in the nature of nucleic acid for industrial or scientific purposes; Reagents for research purposes
• GS0441: Medical and veterinary services, in particular for therapeutic and preventative treatment of tumour diseases, infectious diseases, autoimmune disorders and allergies, for treatment of inherited genetic diseases or for protein or enzyme replacement therapy, and for treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, and for treatment of metabolic disorders
• DS0000: "RNA"
• GS0421: Scientific and technological services, namely, technical biology consulting and scientific research services, in particular for identifying and characterizing biological macromolecules; pre-clinical and clinical testing of macromolecules

Case File Event Statements

• 10/13/2018 - 6 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 10/20/2018 - 6 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 1/22/2019 - 5 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 1/23/2019 - 5 years ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 1/23/2019 - 5 years ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 1/23/2019 - 5 years ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 7/23/2019 - 5 years ago

  7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 7/29/2019 - 5 years ago

  8 - ASSIGNED TO LIE Type: ALIE

• 7/29/2019 - 5 years ago

  9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 7/29/2019 - 5 years ago

  10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 8/7/2019 - 5 years ago

  11 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 8/7/2019 - 5 years ago

  14 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 8/7/2019 - 5 years ago

  12 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 8/7/2019 - 5 years ago

  13 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 8/7/2019 - 5 years ago

  15 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 8/21/2019 - 5 years ago

  16 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 9/10/2019 - 5 years ago

  17 - PUBLISHED FOR OPPOSITION Type: PUBO

• 9/10/2019 - 5 years ago

  18 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 11/26/2019 - 5 years ago

  19 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 5/25/2022 - 2 years ago

  20 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN

• 11/26/2024 - a month ago

  21 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Type: REM1

• 12/4/2024 - 22 days ago

  22 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN